PLASMAFLO OP OP-08W N/A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2019-03-20 for PLASMAFLO OP OP-08W N/A manufactured by Asahi Kasei Medical Co., Ltd..

Event Text Entries

[139292618] This incident occurred in (b)(6) and is reported to fda according to the requirement. Plasmaflo op-08w is similar product of plasmaflo op-05w(a) marketed in us, and is used as plasma separator. We reviewed manufacturing records, quality records of lot# mh4z4l. As a result, no abnormality was found in records. 1,380 units of this lot# mh4z4l were manufactured, and no similar event using this lot# mh4z4l was reported globally. Physician considered that this event was serious adverse event of "hemolysis", and the causal relationship between this event and plasmaflo op could not be denied. We could not obtain detail information of this event, according to physician's comment, we considered that this event was serious, and that the causal relationship between plasmaflo op and this event could not be denied because the adverse event occurred during the treatment with op-08w. Hemolysis is described in the package insert of plasmaflo op (i. Preface, e. Precautions): 12. Hemolysis is an adverse reaction that can occur if the tmp increases above 100mmhg (13. 3kpa). 13. Monitor the patient constantly during treatment with the plasmaflo? Op-05w(a). In the event of any of the following during treatment, immediately ensure the safety of the patient and take appropriate measures in accordance with the directions of the responsible physician. ? E presence of hemoglobin in separated plasma, due to hemolysis. We will carefully continue to monitor and to be vigilant for the trend of occurrence of this kind of adverse events.
Patient Sequence No: 1, Text Type: N, H10


[139292619] A patient was in the condition of chronic renal failure in (b)(6). The patient was planned to have a kidney-transplant surgery, and double filtration plasmapheresis (dfpp) treatment was required to performed because of the patient's high level of antibodies. (b)(6) 2019: after 10 minutes from the blood was introduced to the circulation of dfpp using plasmaflo op-08w used as plasma separator, which is similar product of plasmaflo op-05w(a) marketed in us, bright red liquid was observed in the plasma-room. The doctor thought it may be a hemolysis reaction, and the treatment was stopped. The liquid sample was sent for further test (hemolysis was confirmed). The patient recovered.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8010002-2019-00030
MDR Report Key8435441
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2019-03-20
Date of Report2019-02-25
Date of Event2019-01-24
Date Mfgr Received2019-02-25
Device Manufacturer Date2018-04-21
Date Added to Maude2019-03-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. AKITAKE YAMASHITA
Manufacturer Street1-1-2 YURAKUCHO, CHIYODA-KU
Manufacturer CityTOKYO 100-0006
Manufacturer CountryJA
Manufacturer Postal100-0006
Manufacturer G1ASAHI KASEI MEDICAL MT CORP.
Manufacturer StreetOITA WORKS 2111-2 OAZA SATO
Manufacturer CityOITA-SHI, OITA 870-0396
Manufacturer CountryJA
Manufacturer Postal Code870-0396
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePLASMAFLO OP
Generic NamePLASMA SEPARATOR
Product CodeMDP
Date Received2019-03-20
Returned To Mfg2019-03-06
Model NumberOP-08W
Catalog NumberN/A
Lot NumberMH4Z4L
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerASAHI KASEI MEDICAL CO., LTD.
Manufacturer Address1-1-2 YURAKUCHO CHIYODA-KU TOKYO 100-0006 JA 100-0006


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2019-03-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.